Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Qixingcha is a traditional Chinese herbal medicine formula used primarily in pediatric care to promote digestion, relieve dyspepsia, and treat constipation. It has been applied for hundreds of years in China for children’s digestive issues. The formulation exhibits prokinetic and laxative effects by enhancing intestinal transit and improving fecal output, as demonstrated in animal models of constipation. Additionally, it has immune-regulating properties that protect the colonic mucosal barrier and modulate inflammatory cytokines such as IL-10 and TNF-α. The formula is composed of multiple herbal ingredients including Coix lacryma-jobi seed (Yiyiren), Crataegus pinnatifida fruit (Shanzha), Cicada molting (Chantui), Glycyrrhiza glabra root (Gancao), Lophatherum gracile leaf (Danzhuye), Oryza sativa seed (Daoya), Uncaria rhynchophylla twig (Gouteng) among others. It is administered orally typically as granules dissolved in warm water for children with symptoms like indigestion, loss of appetite, irritability, or constipation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoer Qixingcha.